Manufacturing Process and Controls: Avoiding Assessment Issues (26of28) GDF - Apr. 3-4, 2019
Рет қаралды 1,314
Күн бұрынCDER Office of Pharmaceutical Quality’s Yaodong (Tony) Huang presents case studies on how common assessment issues could potentially turn into a major deficiency/approvability issues.
Learn more at www.fda.gov/dr...
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Visit www.fda.gov/cd... and www.fda.gov/cd... for news and a repository of training activities.
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
LinkedIn: / cder-small-business-an...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...
Deficiencies and Observations from Facility Evaluations and Inspections(27of28) GDF - Apr. 3-4, 2019
U.S. Food and Drug Administration
Рет қаралды 1,1 М.
U.S. Food and Drug Administration
Рет қаралды 8 М.
i_roblox_queen
Рет қаралды 1,1 МЛН
U.S. Food and Drug Administration
Рет қаралды 2,7 М.
U.S. Food and Drug Administration
Рет қаралды 527
U.S. Food and Drug Administration
Рет қаралды 724
U.S. Food and Drug Administration
Рет қаралды 1 М.
U.S. Food and Drug Administration
Рет қаралды 1,4 М.
U.S. Food and Drug Administration
Рет қаралды 992
U.S. Food and Drug Administration
Рет қаралды 739
U.S. Food and Drug Administration
Рет қаралды 530
U.S. Food and Drug Administration
Рет қаралды 86 М.